Annotated table of contents  by unknown
Editorials 1 The Editorial Board of The Journal of Thoracic and Cardiovascular Surgery
Andrew S. Wechsler, MD, Philadelphia, Pa
2 Editorial Board: 2003-2004
5 Radial versus right internal thoracic artery as a second arterial conduit for
coronary surgery: Early and midterm outcomes Œ
Bruce W. Lytle, MD, Cleveland, Ohio
7 Is there a hypercoagulable state after off-pump coronary artery bypass
surgery? What do we know and what can we do?
Paul A. Kurlansky, MD, Miami Beach, Fla
General Thoracic
Surgery
(GTS)
11 Positron emission tomography defines metastatic disease but not locoregional
disease in patients with malignant pleural mesothelioma
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CT and MRI often fail to predict resectability in patients with MPM. We analyzed our
experience to determine more definitively the potential utility of FDG-PET.
17 Value of accelerated multimodality therapy in stage IIIA and IIIB non–small
cell lung cancer
Malcolm M. DeCamp, MD, Thomas W. Rice, MD, David J. Adelstein, MD,
Mark A. Chidel, MD, Lisa A. Rybicki, MS, Sudish C. Murthy, MD, PhD, and
Eugene H. Blackstone, MD, Cleveland, Ohio
Accelerated multimodality therapy is equally valuable in IIIA and IIIB non–small cell lung
cancer. Despite unpredictable response to induction therapy, younger patients with
nonsquamous histology, sterilization of mediastinal lymph nodes, and lower pT benefit most.
Cancer status of ypN2 reduces, but does not preclude, long-term survival.
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growth in syngeneic murine models of thoracic malignancies
Ali Mahtabifard, MD, Robert E. Merritt, MD, Reiko E. Yamada, BA, Ronald G. Crystal, MD,
and Robert J. Korst, MD, New York, NY
Adenovirus-mediated gene transfer of human pigment epithelium-derived factor, a newly
described potent antiangiogenic protein, suppresses both tumor vascularization and growth,
while prolonging survival in murine models of thoracic malignancies.
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39 Radial versus right internal thoracic artery as a second arterial conduit for
coronary surgery: Early and midterm outcomes Œ
Massimo Caputo, MD, Barnaby Reeves, DPhil, Giovanni Marchetto, MD,
Balakrishnan Mahesh, FRCS, Kelvin Lim, FRCS, and Gianni D. Angelini, FRCS, Bristol,
United Kingdom
Clinical outcomes in patients receiving an RA versus a RITA as the second arterial conduit for
myocardial revascularization were compared. Odds ratios for early clinical outcomes and
estimates for survival free from cardiac-related event or death showed a protective effect when
the RA was used for the second arterial graft rather than the RITA.
48 Persistent abnormal left ventricular systolic torsion in dilated
cardiomyopathy after partial left ventriculectomy
Randolph M. Setser, DSc, Jane M. Kasper, RN, Michael L. Lieber, MS,
Randall C. Starling, MD, Patrick M. McCarthy, MD, and Richard D. White, MD, Cleveland,
Ohio
Left ventricular systolic rotation and torsion were quantified in patients with dilated
cardiomyopathy before and after partial left ventriculectomy. Both were impaired by dilated
cardiomyopathy and further diminished after surgery, despite improvement in clinical indices of
ventricular function.
56 Left ventricular systolic performance in failing heart improved acutely by
left ventricular reshaping
Kun-lun He, MD, PhD, Juichiro Shimizu, MD, PhD, Geng-hua Yi, MD, Anguo Gu, MD,
M. Abul Kashem, MD, PhD, Deborah L. Crabbe, MD, Sulli Popilskis, DVM, Ed X. Wu, PhD,
William P. Santamore, PhD, David Melvin, MD, PhD, and Jie Wang, MD, PhD, New York,
NY, Philadelphia, Pa, and Cincinnati, Ohio
The effects of a left ventricular reshaping device on an isolated failing heart preparation and an
intact failing heart in vivo were studied. This device can reshape the left ventricle and improve
left ventricular systolic performance in failing hearts.
66 Long-term durability of the Hancock II porcine bioprosthesis
Giulio Rizzoli, MD, Tomaso Bottio, MD, Gaetano Thiene, MD, Giuseppe Toscano, MD, and
Dino Casarotto, MD, Padua, Italy
Thirty of 212 patients receiving Hancock II prostheses (Medtronic, Inc, Minneapolis, Minn)
were followed up for 15 years. Actual freedom from structural deterioration was 95%  3.0%
in older patients versus 84.5%  3.5% in patients younger than 65 years, and in the latter
group, these values were 92%  4.5% versus 82%  4.2% in the aortic and mitral positions,
respectively. We recommend Hancock II use in patients older than 65 years, as well as in
younger patients having aortic valve replacement.
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75 The “clover technique” as a novel approach for correction of post-traumatic
tricuspid regurgitation
O. Alfieri, MD, M. De Bonis, MD, E. Lapenna, MD, E. Agricola, MD, A. Quarti, MD, and
F. Maisano, MD, Milan, Italy
Five patients with severe post-traumatic tricuspid regurgitation underwent valve repair with a
novel technique named “clover,” which has never been described so far. This approach proved
to be an easy, rapid, and effective option to correct complex tricuspid valve lesions associated
with right ventricular enlargement/dysfunction due to long-standing chronic volume overload.
80 Long-term evaluation of Carpentier-Edwards porcine bioprosthesis for
rheumatic heart disease
Hsi-Yu Yu, MD, Yi-Lwun Ho, MD, Shu-Hsun Chu, MD, Yih-Sharng Chen, MD,
Shoei-Shen Wang, MD, and Fang-Yue Lin, MD, Taipei, Taiwan
A total of 872 patients in our hospital underwent valvular heart surgery with CES porcine
bioprosthesis replacement and were followed up for up to 24 years. Actuarial patient survival
was 83.8% and 35.8% at 10 and 20 years, respectively. Freedom from structural valvular
failure was 63.7% and 7.7% at 10 and 20 years, respectively. The long-term survival is higher,
but freedom from valve failure rate is lower than that of Western series.
90 An in vitro assessment by means of laser Doppler velocimetry of the
Medtronic Advantage bileaflet mechanical heart valve hinge flow
Rahul Saxena, MS, Jack Lemmon, PhD, Jeffrey Ellis, PhD, and Ajit Yoganathan, PhD,
Atlanta, Ga
The aim of this study was to assess the hinge flow dynamics of the new Medtronic Advantage
bileaflet mechanical valve design and to compare the results with those of the St Jude Medical
hinge design. This comparison provides information on preclinical efficacy related to adequate
washing of the hinge region during the cardiac cycle.
99 Hancock II bioprosthesis: A glance at the microscope in mid–long-term
explants
Tomaso Bottio, Gaetano Thiene, Elena Pettenazzo, Paolo Ius, Uberto Bortolotti, Giulio Rizzoli,
Carlo Valfre´, Dino Casarotto, and Marialuisa Valente, Padua and Treviso, Italy
Structural valve deterioration due to dystrophic calcification occurred rarely and late in
Hancock II bioprostheses, suggesting an efficacy of the anti-calcification treatment T6.
Although valve failure is delayed, other factors, such as lipid insudation, may come into play in
the long term.
106 Candidate locus analysis of familial ascending aortic aneurysms and
dissections confirms the linkage to the chromosome 5q13-14 in Finnish
families
Sakari Kakko, MD, PhD, Tuija Ra¨isa¨nen, MSc, Minna Tamminen, MD, PhD,
Juhani Airaksinen, MD, PhD, Kaj Groundstroem, MD, PhD, Tatu Juvonen, MD, PhD,
Antti Ylitalo, MD, PhD, Paavo Uusimaa, MD, PhD, and Markku J. Savolainen, MD, PhD,
Oulu, Turku, Tampere, and Pori, Finland
The chromosomal location 5q13–14 was found to be linked to the risk of developing
aneurysms and dissections of the ascending aorta in 11 Finnish families.
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114 Transcoronary implantation of bone marrow stromal cells ameliorates
cardiac function after myocardial infarction
Takayuki Saito, MD, PhD, Jin-Qiang Kuang, MD, Charles C. H. Lin, BSc, and
Ray C.-J. Chiu, MD, PhD, Montreal, Quebec, Canada, and Nagoya, Japan
Although bone marrow stromal cells had been reported to improve cardiac function when
injected directly into the myocardial scar, this study demonstrated for the first time that bone
marrow stromal cells can be delivered via the coronary artery, as they are capable of targeted
migration and differentiation into cardiomyocytes in the scar tissue to improve cardiac function.
124 Cardiomyocyte-mediated contact programs human mesenchymal stem cells
to express cardiogenic phenotype
Sunil Rangappa, MD, John W. C. Entwistle, PhD, MD, Andrew S. Wechsler, MD, and
J. Yasha Kresh, MD, Philadelphia, Pa
The microenvironment is pivotal in dictating adult stem cell lineage commitment and
differentiation. The role of cell-to-cell contact in directing human mesenchymal stem cells
(hMSCs) to cardiogenic phenotype was studied. The findings suggest that in addition to soluble
signaling molecules, physical cell-to-cell contact was obligatory in relaying microenvironment-
dependent signals ultimately responsible for differentiation of hMSCs to cardiomyocytes.
133 Protection of the human heart with ischemic preconditioning during cardiac
surgery: Role of cardiopulmonary bypass
Sudip Ghosh, MD, and Manuel Galin˜anes, MD, PhD, FRCS, Leicester, United Kingdom
Studies on the effects of IP in the human heart have yielded conflicting results and therefore
remain controversial. Our studies suggest that IP is protective in patients undergoing coronary
artery surgery on the beating heart without the use of CPB, but that it offers no additional
benefit when associated with CPB regardless of the mode of cardioprotection used, because
CPB per se induces preconditioning.
143 The aging human myocardium: Tolerance to ischemia and responsiveness to
ischemic preconditioning
Mahmoud Loubani, FRCSI, Sudip Ghosh, FRCS, and Manuel Galin˜anes, MD, PhD, FRCS,
Leicester, United Kingdom
This study investigated the effect of increasing age on the tolerance of the human myocardium
to ischemia and the responsiveness to ischemic preconditioning. Age did not influence the
tolerance of the human myocardium to ischemia or the protective effect of ischemic
preconditioning. These results indicate that the importance of age in risk scoring in cardiac
surgery should be reevaluated.
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148 Integrated pharmacological preconditioning in combination with adenosine,
a mitochondrial KATP channel opener and a nitric oxide donor
Yuka Uchiyama, MD, Hajime Otani, MD, Takayuki Okada, MD, Takamichi Uchiyama, MD,
Hideki Ninomiya, MD, Masakuni Kido, MD, Hiroji Imamura, MD, Shinichi Nakao, MD, and
Koh Shingu, MD, Moriguchi City, Japan
Pharmacological preconditioning, in combination with adenosine, diazoxide, and a nitric oxide
donor but not each alone or in combination with two of them, conferred powerful
cardioprotection comparable to ischemic preconditioning. This integrated pharmacological
preconditioning is presumably mediated through amplified protein kinase C signaling promoted
by coordinated interaction of adenosine, mitochondrial KATP channel activation, and nitric
oxide.
160 Doppler microembolic load predicts risk of thromboembolic complications in
Novacor patients
Darius G. Nabavi, MD, Joerg Stockmann, MD, Christof Schmid, MD, Michael Schneider, MD,
Dieter Hammel, MD, Hans H. Scheld, MD, and E. Bernd Ringelstein, MD, Mu¨nster, Germany
This prospective study evaluated the predictive value of Doppler microembolic signals (MES)
in 20 patients supported with the Novacor LVAD. MES activity correlated significantly with
the individual risk of thromboembolic complications. The high negative predictive value allows
identification of those LVAD patients at low risk of thromboembolic complications, which
could guide therapeutic decisions.
168 Clinical and six-month angiographic evaluation of coronary arterial graft
interrupted anastomoses by use of a self-closing clip device: A multicenter
prospective clinical trial
Randall K. Wolf, MD, Edwin L. Alderman, MD, Michael P. Caskey, MD,
Allen R. Raczkowski, MD, Mercedes K. Dullum, MD, Dwight C. Lundell, MD,
Arthur C. Hill, MD, Nan Wang, MD, and Michael A. Daniel, MS, MBA, Columbus, Ohio; Palo
Alto, Calif; Phoenix and Mesa, Ariz; Washington, DC; Omaha, Neb; Riyadh, Saudi Arabia;
and Orinda, Calif
Safety and effectiveness of a self-closing anastomotic clip was evaluated in a prospective,
multicenter, clinical trial. Eighty-two LITA-LAD anastomoses were completed with
independent angiographic laboratory quantitative evaluation of 63 (77%) angiograms at an
average of 6 months. Results confirmed superior anastomotic patency resulting from the
compliant interrupted technique.
179 Detrimental effects of papaverine on the human internal thoracic artery
Yu-Jing Gao, MD, Homer Yang, MD, Kevin Teoh, MD, and Robert M. K. W. Lee, PhD,
Hamilton, Ontario, Canada
Papaverine impairs endothelial function and induces apoptosis of endothelial and smooth
muscle cells of human and canine internal thoracic arteries. The long-term consequence of this
impairment on vascular function is unknown. Because the integrity of graft tissue is important
for its function, we suggest that it will be prudent to use other vasodilators that are less
damaging to the internal thoracic artery for cardiac surgery.
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